img

Global In-vitro Toxicity Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global In-vitro Toxicity Testing Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

In-vitro and in-silico testing methods are being preferred over in-vivo testing methods in the pharmaceutical industry because of the growing need to detect diseases at the molecular level and identify biological functionalities with minimal adverse effects.
Due to the COVID-19 pandemic, the global In-vitro Toxicity Testing market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Static Well Plate System accounting for % of the In-vitro Toxicity Testing global market in 2022, is projected to value US$ million by 2034, growing at a revised % CAGR from 2024 to 2034. While Pharmaceutical and Biotechnology Companies segment is altered to an % CAGR throughout this forecast period.
The development of advanced technologies, such as 3D cell culture technologies, cellular imaging technologies, and toxicogenomics has further supported the adoption of in-vitro testing methods. These technologies help in replicating in-vivo systems and thereby eliminate the need to experiment on human or animal models.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global In-vitro Toxicity Testing market. The analysts authoring the report have closely studied key strategies adopted by top players of the global In-vitro Toxicity Testing market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global In-vitro Toxicity Testing market. Readers of the report can become informed about current and future trends of the global In-vitro Toxicity Testing market and how they will impact market growth during the forecast period.



By Company


Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
CELTHER POLSKA Sp z o.o.
Charles River Laboratories International Inc.
Eurofins GSC Lux Sarl
Evotec AG
General Electric Co.
Merck KGaA
Thermo Fisher Scientific Inc.
Segment by Type
Static Well Plate System
Multi-compartmental Perfused Systems

Segment by Application


Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of In-vitro Toxicity Testing in global and regional level.
Chapter 3Detailed analysis of In-vitro Toxicity Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-vitro Toxicity Testing revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Static Well Plate System
1.2.3 Multi-compartmental Perfused Systems
1.3 Market by Application
1.3.1 Global In-vitro Toxicity Testing Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academic and Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global In-vitro Toxicity Testing Market Size (2018-2034)
2.2 In-vitro Toxicity Testing Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global In-vitro Toxicity Testing Market Size by Region (2018-2024)
2.4 Global In-vitro Toxicity Testing Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 In-vitro Toxicity Testing Countries Ranking by Market Size
3 In-vitro Toxicity Testing Competitive by Company
3.1 Global In-vitro Toxicity Testing Revenue by Players
3.1.1 Global In-vitro Toxicity Testing Revenue by Players (2018-2024)
3.1.2 Global In-vitro Toxicity Testing Market Share by Players (2018-2024)
3.2 Global In-vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by In-vitro Toxicity Testing Revenue
3.4 Global In-vitro Toxicity Testing Market Concentration Ratio
3.4.1 Global In-vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Toxicity Testing Revenue in 2022
3.5 Global Key Players of In-vitro Toxicity Testing Head office and Area Served
3.6 Global Key Players of In-vitro Toxicity Testing, Product and Application
3.7 Global Key Players of In-vitro Toxicity Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global In-vitro Toxicity Testing Breakdown Data by Type
4.1 Global In-vitro Toxicity Testing Historic Revenue by Type (2018-2024)
4.2 Global In-vitro Toxicity Testing Forecasted Revenue by Type (2024-2034)
5 Global In-vitro Toxicity Testing Breakdown Data by Application
5.1 Global In-vitro Toxicity Testing Historic Market Size by Application (2018-2024)
5.2 Global In-vitro Toxicity Testing Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America In-vitro Toxicity Testing Revenue by Company (2021-2024)
6.2 North America In-vitro Toxicity Testing Revenue by Type (2018-2034)
6.3 North America In-vitro Toxicity Testing Revenue by Application (2018-2034)
6.4 North America In-vitro Toxicity Testing Revenue by Country (2018-2034)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe In-vitro Toxicity Testing Revenue by Company (2021-2024)
7.2 Europe In-vitro Toxicity Testing Revenue by Type (2018-2034)
7.3 Europe In-vitro Toxicity Testing Revenue by Application (2018-2034)
7.4 Europe In-vitro Toxicity Testing Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific In-vitro Toxicity Testing Revenue by Company (2021-2024)
8.2 Asia Pacific In-vitro Toxicity Testing Revenue by Type (2018-2034)
8.3 Asia Pacific In-vitro Toxicity Testing Revenue by Application (2018-2034)
8.4 Asia Pacific In-vitro Toxicity Testing Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America In-vitro Toxicity Testing Revenue by Company (2021-2024)
9.2 Latin America In-vitro Toxicity Testing Revenue by Type (2018-2034)
9.3 Latin America In-vitro Toxicity Testing Revenue by Application (2018-2034)
9.4 Latin America In-vitro Toxicity Testing Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa In-vitro Toxicity Testing Revenue by Company (2021-2024)
10.2 Middle East and Africa In-vitro Toxicity Testing Revenue by Type (2018-2034)
10.3 Middle East and Africa In-vitro Toxicity Testing Revenue by Application (2018-2034)
10.4 Middle East and Africa In-vitro Toxicity Testing Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories In-vitro Toxicity Testing Products and Services
11.1.4 Abbott Laboratories In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.1.5 Abbott Laboratories In-vitro Toxicity Testing SWOT Analysis
11.1.6 Abbott Laboratories Recent Development
11.2 Agilent Technologies Inc.
11.2.1 Agilent Technologies Inc. Company Details
11.2.2 Agilent Technologies Inc. Business Overview
11.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Products and Services
11.2.4 Agilent Technologies Inc. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.2.5 Agilent Technologies Inc. In-vitro Toxicity Testing SWOT Analysis
11.2.6 Agilent Technologies Inc. Recent Development
11.3 Bio-Rad Laboratories Inc.
11.3.1 Bio-Rad Laboratories Inc. Company Details
11.3.2 Bio-Rad Laboratories Inc. Business Overview
11.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Products and Services
11.3.4 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.3.5 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing SWOT Analysis
11.3.6 Bio-Rad Laboratories Inc. Recent Development
11.4 CELTHER POLSKA Sp z o.o.
11.4.1 CELTHER POLSKA Sp z o.o. Company Details
11.4.2 CELTHER POLSKA Sp z o.o. Business Overview
11.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Products and Services
11.4.4 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.4.5 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing SWOT Analysis
11.4.6 CELTHER POLSKA Sp z o.o. Recent Development
11.5 Charles River Laboratories International Inc.
11.5.1 Charles River Laboratories International Inc. Company Details
11.5.2 Charles River Laboratories International Inc. Business Overview
11.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Products and Services
11.5.4 Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.5.5 Charles River Laboratories International Inc. In-vitro Toxicity Testing SWOT Analysis
11.5.6 Charles River Laboratories International Inc. Recent Development
11.6 Eurofins GSC Lux Sarl
11.6.1 Eurofins GSC Lux Sarl Company Details
11.6.2 Eurofins GSC Lux Sarl Business Overview
11.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Products and Services
11.6.4 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.6.5 Eurofins GSC Lux Sarl In-vitro Toxicity Testing SWOT Analysis
11.6.6 Eurofins GSC Lux Sarl Recent Development
11.7 Evotec AG
11.7.1 Evotec AG Company Details
11.7.2 Evotec AG Business Overview
11.7.3 Evotec AG In-vitro Toxicity Testing Products and Services
11.7.4 Evotec AG In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.7.5 Evotec AG In-vitro Toxicity Testing SWOT Analysis
11.7.6 Evotec AG Recent Development
11.8 General Electric Co.
11.8.1 General Electric Co. Company Details
11.8.2 General Electric Co. Business Overview
11.8.3 General Electric Co. In-vitro Toxicity Testing Products and Services
11.8.4 General Electric Co. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.8.5 General Electric Co. In-vitro Toxicity Testing SWOT Analysis
11.8.6 General Electric Co. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Details
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA In-vitro Toxicity Testing Products and Services
11.9.4 Merck KGaA In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.9.5 Merck KGaA In-vitro Toxicity Testing SWOT Analysis
11.9.6 Merck KGaA Recent Development
11.10 Thermo Fisher Scientific Inc.
11.10.1 Thermo Fisher Scientific Inc. Company Details
11.10.2 Thermo Fisher Scientific Inc. Business Overview
11.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Products and Services
11.10.4 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024)
11.10.5 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing SWOT Analysis
11.10.6 Thermo Fisher Scientific Inc. Recent Development
12 In-vitro Toxicity Testing Market Dynamics
12.1 In-vitro Toxicity Testing Industry Trends
12.2 In-vitro Toxicity Testing Market Drivers
12.3 In-vitro Toxicity Testing Market Challenges
12.4 In-vitro Toxicity Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global In-vitro Toxicity Testing Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Static Well Plate System
Table 3. Key Players of Multi-compartmental Perfused Systems
Table 4. Global In-vitro Toxicity Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 5. Global In-vitro Toxicity Testing Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 6. Global In-vitro Toxicity Testing Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global In-vitro Toxicity Testing Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 8. Global In-vitro Toxicity Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 9. Global In-vitro Toxicity Testing Revenue by Players (2018-2024) & (US$ Million)
Table 10. Global In-vitro Toxicity Testing Market Share by Players (2018-2024)
Table 11. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Toxicity Testing as of 2022)
Table 12. Ranking of Global Top In-vitro Toxicity Testing Companies by Revenue (US$ Million) in 2022
Table 13. Global 5 Largest Players Market Share by In-vitro Toxicity Testing Revenue (CR5 and HHI) & (2018-2024)
Table 14. Global Key Players of In-vitro Toxicity Testing, Headquarters and Area Served
Table 15. Global Key Players of In-vitro Toxicity Testing, Product and Application
Table 16. Global Key Players of In-vitro Toxicity Testing, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global In-vitro Toxicity Testing Market Size by Type (2018-2024) & (US$ Million)
Table 19. Global In-vitro Toxicity Testing Revenue Market Share by Type (2018-2024)
Table 20. Global In-vitro Toxicity Testing Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 21. Global In-vitro Toxicity Testing Revenue Market Share by Type (2024-2034)
Table 22. Global In-vitro Toxicity Testing Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global In-vitro Toxicity Testing Revenue Market Share by Application (2018-2024)
Table 24. Global In-vitro Toxicity Testing Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global In-vitro Toxicity Testing Revenue Market Share by Application (2024-2034)
Table 26. North America In-vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 27. North America In-vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 28. North America In-vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 29. North America In-vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 30. North America In-vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 31. North America In-vitro Toxicity Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 32. North America In-vitro Toxicity Testing Revenue by Country (2018-2024) & (US$ Million)
Table 33. North America In-vitro Toxicity Testing Revenue by Country (2024-2034) & (US$ Million)
Table 34. Europe In-vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 35. Europe In-vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 36. Europe In-vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 37. Europe In-vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 38. Europe In-vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 39. Europe In-vitro Toxicity Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 40. Europe In-vitro Toxicity Testing Revenue by Country (2018-2024) & (US$ Million)
Table 41. Europe In-vitro Toxicity Testing Revenue by Country (2024-2034) & (US$ Million)
Table 42. Asia Pacific In-vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 43. Asia Pacific In-vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 44. Asia Pacific In-vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 45. Asia Pacific In-vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 46. Asia Pacific In-vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 47. Asia-Pacific In-vitro Toxicity Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 48. Asia Pacific In-vitro Toxicity Testing Revenue by Region (2018-2024) & (US$ Million)
Table 49. Asia Pacific In-vitro Toxicity Testing Revenue by Region (2024-2034) & (US$ Million)
Table 50. Latin America In-vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 51. Latin America In-vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 52. Latin America In-vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 53. Latin America In-vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 54. Latin America In-vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 55. Latin America In-vitro Toxicity Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 56. Latin America In-vitro Toxicity Testing Revenue by Country (2018-2024) & (US$ Million)
Table 57. Latin America In-vitro Toxicity Testing Revenue by Country (2024-2034) & (US$ Million)
Table 58. Middle East and Africa In-vitro Toxicity Testing Revenue by Company (2021-2024) & (US$ Million)
Table 59. Middle East and Africa In-vitro Toxicity Testing Revenue by Type (2018-2024) & (US$ Million)
Table 60. Middle East and Africa In-vitro Toxicity Testing Revenue by Type (2024-2034) & (US$ Million)
Table 61. Middle East and Africa In-vitro Toxicity Testing Revenue by Application (2018-2024) & (US$ Million)
Table 62. Middle East and Africa In-vitro Toxicity Testing Revenue by Application (2024-2034) & (US$ Million)
Table 63. Middle East and Africa In-vitro Toxicity Testing Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 64. Middle East and Africa In-vitro Toxicity Testing Revenue by Country (2018-2024) & (US$ Million)
Table 65. Middle East and Africa In-vitro Toxicity Testing Revenue by Country (2024-2034) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories In-vitro Toxicity Testing Product and Services
Table 69. Abbott Laboratories In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 70. Abbott Laboratories In-vitro Toxicity Testing SWOT Analysis
Table 71. Abbott Laboratories Recent Development
Table 72. Agilent Technologies Inc. Company Details
Table 73. Agilent Technologies Inc. Business Overview
Table 74. Agilent Technologies Inc. In-vitro Toxicity Testing Product and Services
Table 75. Agilent Technologies Inc. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 76. Agilent Technologies Inc. In-vitro Toxicity Testing SWOT Analysis
Table 77. Agilent Technologies Inc. Recent Development
Table 78. Bio-Rad Laboratories Inc. Company Details
Table 79. Bio-Rad Laboratories Inc. Business Overview
Table 80. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product and Services
Table 81. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 82. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing SWOT Analysis
Table 83. Bio-Rad Laboratories Inc. Recent Development
Table 84. CELTHER POLSKA Sp z o.o. Company Details
Table 85. CELTHER POLSKA Sp z o.o. Business Overview
Table 86. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product and Services
Table 87. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 88. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing SWOT Analysis
Table 89. CELTHER POLSKA Sp z o.o. Recent Development
Table 90. Charles River Laboratories International Inc. Company Details
Table 91. Charles River Laboratories International Inc. Business Overview
Table 92. Charles River Laboratories International Inc. In-vitro Toxicity Testing Product and Services
Table 93. Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 94. Charles River Laboratories International Inc. In-vitro Toxicity Testing SWOT Analysis
Table 95. Charles River Laboratories International Inc. Recent Development
Table 96. Eurofins GSC Lux Sarl Company Details
Table 97. Eurofins GSC Lux Sarl Business Overview
Table 98. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product and Services
Table 99. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 100. Eurofins GSC Lux Sarl In-vitro Toxicity Testing SWOT Analysis
Table 101. Eurofins GSC Lux Sarl Recent Development
Table 102. Evotec AG Company Details
Table 103. Evotec AG Business Overview
Table 104. Evotec AG In-vitro Toxicity Testing Product and Services
Table 105. Evotec AG In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 106. Evotec AG In-vitro Toxicity Testing SWOT Analysis
Table 107. Evotec AG Recent Development
Table 108. General Electric Co. Company Details
Table 109. General Electric Co. Business Overview
Table 110. General Electric Co. In-vitro Toxicity Testing Product and Services
Table 111. General Electric Co. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 112. General Electric Co. In-vitro Toxicity Testing SWOT Analysis
Table 113. General Electric Co. Recent Development
Table 114. Merck KGaA Company Details
Table 115. Merck KGaA Business Overview
Table 116. Merck KGaA In-vitro Toxicity Testing Product and Services
Table 117. Merck KGaA In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 118. Merck KGaA In-vitro Toxicity Testing SWOT Analysis
Table 119. Merck KGaA Recent Development
Table 120. Thermo Fisher Scientific Inc. Company Details
Table 121. Thermo Fisher Scientific Inc. Business Overview
Table 122. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product and Services
Table 123. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue in In-vitro Toxicity Testing Business (2018-2024) & (US$ Million)
Table 124. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing SWOT Analysis
Table 125. Thermo Fisher Scientific Inc. Recent Development
Table 126. In-vitro Toxicity Testing Market Trends
Table 127. In-vitro Toxicity Testing Market Drivers
Table 128. In-vitro Toxicity Testing Market Challenges
Table 129. In-vitro Toxicity Testing Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. In-vitro Toxicity Testing Product Picture
Figure 2. Global In-vitro Toxicity Testing Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global In-vitro Toxicity Testing Market Share by Type: 2022 VS 2034
Figure 4. Static Well Plate System Features
Figure 5. Multi-compartmental Perfused Systems Features
Figure 6. Global In-vitro Toxicity Testing Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 7. Global In-vitro Toxicity Testing Market Share by Application: 2022 VS 2034
Figure 8. Pharmaceutical and Biotechnology Companies
Figure 9. Academic and Research Institutions
Figure 10. Others
Figure 11. In-vitro Toxicity Testing Report Years Considered
Figure 12. Global In-vitro Toxicity Testing Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global In-vitro Toxicity Testing Market Size 2018-2034 (US$ Million)
Figure 14. Global In-vitro Toxicity Testing Market Size Market Share by Region: 2022 VS 2034
Figure 15. Global In-vitro Toxicity Testing Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global In-vitro Toxicity Testing Revenue Market Share Forecast by Region (2024-2034)
Figure 17. Global Top 10 In-vitro Toxicity Testing Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global In-vitro Toxicity Testing Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 19. Global In-vitro Toxicity Testing Market Share by Players in 2022
Figure 20. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Toxicity Testing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by In-vitro Toxicity Testing Revenue in 2022
Figure 22. North America In-vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 23. North America In-vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 24. North America In-vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 25. North America In-vitro Toxicity Testing Revenue Share by Country (2018-2034)
Figure 26. U.S. In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 27. Canada In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 28. Europe In-vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 29. Europe In-vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 30. Europe In-vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 31. Europe In-vitro Toxicity Testing Revenue Share by Country (2018-2034)
Figure 32. Germany In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 33. France In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 34. U.K. In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 35. Italy In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 36. Russia In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 37. Asia Pacific In-vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 38. Asia Pacific In-vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 39. Asia Pacific In-vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 40. Asia Pacific In-vitro Toxicity Testing Revenue Share by Region (2018-2034)
Figure 41. China In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 42. Japan In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 43. South Korea In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 44. India In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 45. Australia In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 46. Taiwan In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 47. Indonesia In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 48. Thailand In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 49. Malaysia In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 50. Philippines In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 51. Vietnam In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 52. Latin America In-vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 53. Latin America In-vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 54. Latin America In-vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 55. Latin America In-vitro Toxicity Testing Revenue Share by Country (2018-2034)
Figure 56. Mexico In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 57. Brazil In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 58. Argentina In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 59. Middle East and Africa In-vitro Toxicity Testing Revenue Market Share by Company in 2022
Figure 60. Middle East and Africa In-vitro Toxicity Testing Revenue Market Share by Type (2018-2034)
Figure 61. Middle East and Africa In-vitro Toxicity Testing Revenue Market Share by Application (2018-2034)
Figure 62. Middle East and Africa In-vitro Toxicity Testing Revenue Share by Country (2018-2034)
Figure 63. Turkey In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 64. Saudi Arabia In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 65. U.A.E In-vitro Toxicity Testing Revenue (2018-2034) & (US$ Million)
Figure 66. Abbott Laboratories Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 67. Agilent Technologies Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 68. Bio-Rad Laboratories Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 69. CELTHER POLSKA Sp z o.o. Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 70. Charles River Laboratories International Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 71. Eurofins GSC Lux Sarl Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 72. Evotec AG Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 73. General Electric Co. Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 74. Merck KGaA Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 75. Thermo Fisher Scientific Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries